Answers are grounded in this paper and cite their sources.
Objective Immunosenescence, characterised by progressive immune dysfunction and chronic low-grade inflammation, is a major contributor to age-related diseases. However, the molecular mechanisms underlying the anti-immunosenescence effects of Astragalus membranaceus (AM) remain unclear. This study integrated network pharmacology, bioinformatics, and molecular modelling to systematically investigate the potential mechanisms by which AM modulates immune ageing. Methods Bioactive compounds and targets of AM were screened using TCMSP and literature mining. Overlapping targets with immunosenescence-related genes were identified to construct compound–target–disease and protein–protein interaction networks. Hub targets were determined through network topology analysis. Transcriptomic differential expression, gene set enrichment, and immune infiltration analyses were performed to elucidate functional pathways and immune alterations. Molecular docking and molecular dynamics simulations were conducted for representative compound–target pairs. Results 21 active compounds and 42 potential targets were identified. Core targets included IL-6, TNF, IL-1β, STAT3, JAK2 and MMP9. KEGG analysis showed significant enrichment in the JAK–STAT, PD-1/PD-L1, Th17 differentiation, and FoxO signalling pathways. Transcriptomic analysis revealed up-regulation of MPO, MMP9, and TNF and down-regulation of RORC in elderly samples. Molecular docking and dynamics analyses demonstrated strong binding affinity and stable interactions between key compounds and core targets. Conclusion Selected candidate bioactive compounds of AM may be associated with the regulation of inflammation, T-cell homeostasis, and immunometabolic remodeling during immunosenescence. The docking and molecular dynamics results provide computational support for several representative compound–target interactions, particularly those involving Astragaloside IV and Calycosin, but they do not demonstrate that all AM constituents exert anti-immunosenescence effects. Further experimental validation is required.
No takes yet. Share an insight, caveat, or question.
Xue et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: